TargetMol

Cytochalasin H

Product Code:
 
TAR-T21513
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T21513-1mg1mg£204.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21513-5mg5mg£389.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21513-10mg10mg£550.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21513-1mL1 mL * 10 mM (in DMSO)£656.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21513-25mg25mg£852.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21513-50mg50mg£1,107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21513-100mg100mg£1,492.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Cytochalasin H is a potent inhibitor of actin incorporation into filaments.
CAS:
53760-19-3
Formula:
C30H39NO5
Molecular Weight:
493.644
Pathway:
Proteases/Proteasome
Purity:
0.98
SMILES:
C[C@H]1C2[C@H](Cc3ccccc3)NC(=O)[C@@]22[C@@H](C=CC[C@H](C)C[C@@](C)(O)C=C[C@H]2OC(C)=O)[C@H](O)C1=C
Target:
MMP

References

1. Ma Y , Xiu Z , Zhou Z , et al. Cytochalasin H Inhibits Angiogenesis via the Suppression of HIF-1? Protein Accumulation and VEGF Expression through PI3K/AKT/P70S6K and ERK1/2 Signaling Pathways in Non-Small Cell Lung Cancer Cells[J]. Journal of Cancer, 2019, 10(9).